Inventor · disambiguated record
Vincenzo Cerullo
Also filed as: CERULLO VINCENZO
10 granted patents·12 pending applications·45 citations·filing 2008–2022
84Inventor score
Files withVALO THERAPEUTICS OY7TILT BIOTHERAPEUTICS OY3TARGOVAX OY2BAYLOR COLLEGE MEDICINE1DIACONU IULIA1
Top patents by PatentIndex Score
22 records- 0189US9410129B2Recombinant serotype 5 (Ad5) adenoviral vectorsTARGOVAX OY·Filed 2012·Granted Aug 9, 2016·28 cites·29 claims
- 0284US10647963B2Enhanced adoptive cell therapyTILT BIOTHERAPEUTICS OY·Filed 2014·Granted May 12, 2020·8 cites·24 claims
- 0382US9345787B2Adenoviral vectors and methods and uses related theretoHEMMINKI AKSELI·Filed 2009·Granted May 24, 2016·8 cites·1 claims
- 0469US12031145B2Cancer therapyVALO THERAPEUTICS OY·Filed 2019·Granted Jul 9, 2024·1 cites·20 claims
- 0561US11730798B2Modified adenoviruses for cancer vaccines developmentVALO THERAPEUTICS OY·Filed 2020·Granted Aug 22, 2023·0 cites·7 claims
- 0660US12421502B2Enhanced adoptive cell therapyTILT BIOTHERAPEUTICS OY·Filed 2020·Granted Sep 23, 2025·0 cites·1 claims
- 0760US2015202324A1Adenoviral vectors and methods and uses related theretoONCOS THERAPEUTICS·Filed 2014·Application pending·0 cites
- 0857US2008311140A1Antigen specific immunosuppression by dendritic cell therapyBAYLOR COLLEGE MEDICINE·Filed 2008·Application pending·0 cites
- 0954US10787645B2Enhanced adoptive cell therapyTILT BIOTHERAPEUTICS OY·Filed 2016·Granted Sep 29, 2020·0 cites·11 claims
- 1053US2024294605A1A cross-hybrid fc-fusion polypeptide targeting pd-l1 and methods and uses related theretoHELSINGIN YLIOPISTO·Filed 2022·Application pending·0 cites
- 1151US2023062122A1Modified adenoviruses for infectious disease vaccine developmentVALO THERAPEUTICS OY·Filed 2022·Application pending·0 cites
- 1249US10799568B2Modified adenoviruses for cancer vaccines developmentVALO THERAPEUTICS OY·Filed 2015·Granted Oct 13, 2020·0 cites·21 claims
- 1349US2016208287A1Adenoviral vectors and methods and uses related theretoTARGOVAX OY·Filed 2016·Application pending·0 cites
- 1444US12337030B2Viral vectorVALO THERAPEUTICS OY·Filed 2020·Granted Jun 24, 2025·0 cites·20 claims
- 1544US2023266307A1BioinformaticsUNIV HELSINKI·Filed 2021·Application pending·0 cites
- 1641US10982194B2Non-genetic modification of enveloped virusesVALO THERAPEUTICS OY·Filed 2017·Granted Apr 20, 2021·0 cites·23 claims
- 1741US2016082100A1RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORSONCOS THERAPEUTICS OY·Filed 2015·Application pending·0 cites
- 1839US2021017501A1Modified oncolytic adenovirusesVALO THERAPEUTICS OY·Filed 2019·Application pending·0 cites
- 1939US2023321209A1Modified mycobacterium bovis vaccinesTHE UNIV OF HELSINKI·Filed 2021·Application pending·0 cites
- 2034US2013323205A1Oncolytic adenoviral vectors and methods and uses related theretoDIACONU IULIA·Filed 2011·Application pending·0 cites
- 2133US2013243731A1Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodiesDIAS JOAO·Filed 2011·Application pending·0 cites
- 2230US2012063995A1Non-ad5 adenoviral vectors and methods and uses related theretoHEMMINKI OTTO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vincenzo Cerullo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →